Your browser doesn't support javascript.
loading
Genetic Mapping of APP and Amyloid-ß Biology Modulation by Trisomy 21.
Mumford, Paige; Tosh, Justin; Anderle, Silvia; Gkanatsiou Wikberg, Eleni; Lau, Gloria; Noy, Sue; Cleverley, Karen; Saito, Takashi; Saido, Takaomi C; Yu, Eugene; Brinkmalm, Gunnar; Portelius, Erik; Blennow, Kaj; Zetterberg, Henrik; Tybulewicz, Victor; Fisher, Elizabeth M C; Wiseman, Frances K.
Afiliación
  • Mumford P; The UK Dementia Research Institute, University College London, London, WC1N 3BG, United Kingdom.
  • Tosh J; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
  • Anderle S; The UK Dementia Research Institute, University College London, London, WC1N 3BG, United Kingdom.
  • Gkanatsiou Wikberg E; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg S-431 80, Sweden.
  • Lau G; The UK Dementia Research Institute, University College London, London, WC1N 3BG, United Kingdom.
  • Noy S; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
  • Cleverley K; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
  • Saito T; Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama Japan, 351-0198.
  • Saido TC; Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama Japan, 351-0198.
  • Yu E; Genetics and Genomics Program and Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Children's Guild Foundation Down Syndrome Research Program, Buffalo, New York NY 14263.
  • Brinkmalm G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg S-431 80, Sweden.
  • Portelius E; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg S-431 80, Sweden.
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg S-431 80, Sweden.
  • Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal S-43180, Sweden.
  • Tybulewicz V; The UK Dementia Research Institute, University College London, London, WC1N 3BG, United Kingdom.
  • Fisher EMC; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg S-431 80, Sweden.
  • Wiseman FK; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal S-43180, Sweden.
J Neurosci ; 42(33): 6453-6468, 2022 08 17.
Article en En | MEDLINE | ID: mdl-35835549
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Down / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Down / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article